Abstract
Background
Obesity is a complex and multifactorial medical condition that can have far reaching consequences on cancer patients, particularly those undergoing treatment such as chemotherapy. Our study focuses to comprehensively explore the various adverse outcomes in obese patients receiving chemotherapy during hospitalization.
Methods
The National Inpatient Sample 2020 was used using the ICD-10 codes to identify patients hospitalized with a primary discharge diagnosis of neoplastic chemotherapy with or without a secondary diagnosis of obesity. Statistical analysis using Stata software was done, and primary and secondary outcomes were obtained after adjusting for confounders using multivariate regression analysis.
Results
Mortality was similar in both obese and non-obese patients. Length of stay and total hospitalization charges were increased in obese patients. Obese patients had higher odds of developing acute respiratory failure and were more likely to require non-invasive and invasive mechanical ventilation.
Conclusion
Our study concluded that obesity could be considered an independent predictor of worse outcomes in patients admitted for neoplastic chemotherapy. Notably, addressing obesity could help to improve the efficacy of treatment for cancer patients while simultaneously reducing any negative consequences associated with being obese.
Similar content being viewed by others
Data availability
The datasets generated and/or analyzed during the current study are available at https://hcupus.ahrq.gov/databases.jsp.
References
Dollinger M. Guidelines for hospitalization for chemotherapy. Oncologist. 1996;1(1 & 2):107–11 (PMID: 10387975).
Kalaycio M. Inpatient management of acute leukemia. Cleve Clin J Med. 1997;64(7):385–9. https://doi.org/10.3949/ccjm.64.7.385. (PMID: 9223768).
Sannu A, Radha R, Mathews A, Padmakumari Mony R, Prahladan A, James FV. Ifosfamide-induced malignancy of ureter and bladder. Cureus. 2017;9(8): e1594. https://doi.org/10.7759/cureus.1594.
Pendergrass TW, Milstein JM, Geyer JR, Mulne AF, Kosnik EJ, Morris JD, et al. Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for pre radiation chemotherapy. J Clin Oncol. 1987;5(8):1221–31. https://doi.org/10.1200/JCO.1987.5.8.1221. (PMID: 3040919).
Dumas JF, Brisson L. Interaction between adipose tissue and cancer cells: role for cancer progression. Cancer Metastasis Rev. 2021;40(1):31–46. https://doi.org/10.1007/s10555-020-09934-2. (Epub 2020 Oct 2 PMID: 33009650).
Furlanetto J, Eiermann W, Marmé F, Reimer T, Reinisch M, Schmatloch S, et al. Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study. Ann Oncol. 2016;27(11):2053–9. https://doi.org/10.1093/annonc/mdw315. (Epub 2016 Aug 8 PMID: 27502721).
IARC Working Group. The evaluation of cancer-preventive interventions. Absence of excess body fatness. , Lyon: International Agency for Research on Cancer; 2021.
Pothiwala P, Jain SK, Yaturu S. Metabolic syndrome and cancer. Metab Syndr Relat Disord. 2009;7(4):279–88. https://doi.org/10.1089/met.2008.0065.
Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ, Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347–60. https://doi.org/10.1016/S0140-6736(02)11403-6. (PMID: 12423980).
Anis AH, Zhang W, Bansback N, Guh DP, Amarsi Z, Birmingham CL. Obesity and overweight in Canada: an updated cost-of-illness study. Obes Rev. 2010;11(1):31–40. https://doi.org/10.1111/j.1467-789X.2009.00579.x. (Epub 2009 Apr 21 PMID: 19413707).
Costa-Font J, Gil J. Obesity and the incidence of chronic diseases in Spain: a seemingly unrelated probit approach. Econ Hum Biol. 2005;3(2):188–214. https://doi.org/10.1016/j.ehb.2005.05.004. (PMID: 15941678).
Petrelli F, Cortellini A, Indini A, Tomasello G, Ghidini M, Nigro O, et al. Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(3): e213520. https://doi.org/10.1001/jamanetworkopen.2021.3520.
Ramdass V, Caskey E, Sklarz T, Ajmeri S, Patel V, Balogun A, et al. Association between obesity and cancer mortality: an internal medicine outpatient clinic perspective. J Clin Med Res. 2021;13(7):377–86. https://doi.org/10.14740/jocmr4543.PMID:34394780,PMCID:PMC8336943.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–38. https://doi.org/10.1056/NEJMoa021423. (PMID: 12711737).
Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2012;7:757–64. https://doi.org/10.2147/COPD.S36997.PMID:23152680;PMCID:PMC3496536.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors have no competing interests to disclose.
Ethics Approval
HCUP Databases Are Limited Data Sets that do not include patients' identification, consent or review by an institutional review board (IRB) is not required for use of limited data sets.
Informed consent
For this type of study, formal consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Javaid, S., Frasier, K. & Chaudhary, A.J. Impact of obesity on in-hospital mortality and morbidity among patients admitted for antineoplastic chemotherapy: a nationwide analysis. Clin Transl Oncol 26, 977–984 (2024). https://doi.org/10.1007/s12094-023-03335-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-023-03335-x